Search Results 131-140 of 14191 for anti-TNF drugs

1. Adjuvant therapy: Treatment to keep cancer from returning - Mayo Clinic

   Which treatments are used as adjuvant therapies? · Chemotherapy. Chemotherapy treats cancer with strong medicines. · Hormone therapy. Some types of cancer are ...

2. Drugs and Supplements that Start with S - Mayo Clinic

   Adalimumab (subcutaneous route). Simlandi. Also known as. Adalimumab-ryvk (subcutaneous route). Simply Allergy. Also known as. Antihistamine (oral route ...

3. Common Mechanisms of Anti-Suicidal Drug Action - Mayo Clinic

   The purpose of this study is to characterize the effects of clozapine, lithium, and ketamine on mTOR signaling, glucose uptake, and overall cellular metabolic ...

4. Drugs and Supplements that Start with E - Mayo Clinic

   Drugs and Supplements. Search prescription and over-the-counter drugs . ... Etanercept (subcutaneous route). Encare. Also known as. Spermicide (vaginal ...

5. Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial - Mayo Clinic

   About this study. Is the treatment strategy of percutaneous left atrial catheter ablation for the purpose of eliminating atrial fibrillation (AF) superior ...

6. Overview - Anticancer Drug Action Laboratory - Mayo Clinic Research

   The Anticancer Drug Action Lab of Scott Kaufmann, M.D., Ph.D., at Mayo Clinic studies the mechanism of action of anti-cancer drugs, tumor cell sensitivity, ...

7. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

   anti-TNF alpha agents) =< 2 weeks prior to randomization, or anticipation of need for systemic immunosuppressive medication during study treatment, with the ...

8. Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... anti-TNF agents, and rituximab). Subjects with an MMT-8 score ≤ 66 (see ...

9. A Study to Evaluate the Effectiveness and Safety of MEDI2070 in Subjects with Active Moderate to Severe Crohn's Disease - Mayo Clinic

   Prior treatment failure or intolerance with at least one Anti-Tumor Necrosis-Factor-Alpha Therapy (anti-TNF α) agent; Effective contraception from screening ...

10. A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF Alpha Inhibitor - Mayo Clinic

    Use of TNFα inhibitor for treatment of RA at time of screening or within the 6 weeks prior to screening. Prior use of biologics for treatment of RA ...